| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $6.2M | -53.6% |
| SG&A Expense | $13.5M | -5.0% |
| Operating Income | -$18.5M | +33.5% |
| Income Tax | $0 | — |
| Net Income | -$25.1M | +16.7% |
| EPS (Basic) | -$2.36 | -490.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -68.6% |
| Current Assets | $3.3M | -52.0% |
| Total Assets | $3.7M | -50.1% |
| Current Liabilities | $21.9M | +14.8% |
| Total Liabilities | $26.9M | +41.1% |
| Stockholders' Equity | -$23.2M | -97.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | +50.9% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $7.5M | +20.7% |